Prostate Cancer Canada

Pilot Grant Program

For more information visit
www.movember.com

In The News

Collaboration and Innovation in Prostate Cancer Research awarded with $5 Million in Movember Team Grants
Toronto, ON – June 11, 2013 – Prostate Cancer Canada (PCC) is proud to announce the recipients of the inaugural Movember Team Grants. The program promotes collaboration between not only researchers but also institutions, providing a united approach to prostate cancer research. The recipient group will receive $5 million in funding. The 2013 Movember Team Grant has been awarded to Dr. Ralph Buttyan of the Vancouver Prostate Centre (Principal Investigator), who leads a team of 22 Co-Investigators. The title of their research is Tumour Cell Plasticity in Treatment-Resistant Prostate Cancer and their study will focus on targeting aggressive and lethal cancer.

Canadians Celebrate Father’s Day and the Men They Love
15 Communities Set to Increase Awareness of Prostate Cancer this Father’s Day TORONTO, ON – June 5, 2013 – Families across Canada will come together this Father’s Day, Sunday, June 16th, to celebrate the men they love at Prostate Cancer Canada’s Safeway Father’s Day Walk/Run. This annual event sponsored by Canada Safeway will see residents in 15 cities across the country lace up their running shoes to raise funds and awareness for prostate cancer.

Click For Information Archive

2012 Pilot Grant Panel

Pilot Grant Established Investigators Panel

Dr Robert Siemens, Chair	Queens University Kingston, ON
Dr Purang Abolmaesumi	University of British Columbia Vancouver, BC
Dr Tarek Bismar	University of Calgary and Rockview Hospital Laboratory Calgary, AB
Dr Mario Chevrette	McGill University Health Centre Montreal, QC
Dr Helga Duivenvoorden	Lakehead University, McMaster University and Juravinski Cancer Centre Hamilton, ON
Dr Gerardo Ferbeyre	University of Montreal Montreal, QC
Dr Anthony Joshua	University of Toronto and Ontario Cancer Institute/University Health Network Toronto, ON
Dr Claude Labrie	Laval University Quebec, QC
Dr Jacques Lapointe	Laval University Quebec, QC
Dr Eric Levesque	Laval University Quebec, QC
Janet E A McDougall	McDougall Scientific Toronto, ON
Dr Jeffrey Medin	Ontario Cancer Institute and Toronto General Research Institute Toronto, ON
Dr Alan So	University of British Columbia and Prostate Centre at Vancouver General Hospital Vancouver, BC
Dr Amina Zoubeidi	University of British Columbia Vancouver, BC
Dr Michael Fraser, Science Officer	Ontario Cancer Centre / University Health Network Toronto, ON
Wayne Harrigan, Lay Member	Moncton, NB

Pilot Grant New Investigators Panel

Dr Jehonathan Pinthus, Chair	McMaster University Hamilton, ON
Dr Richard Austin	McMaster University and St Joseph’s Healthcare Hamilton, ON
Dr Glenn Bauman	University of Western Ontario and London Regional Cancer Program London, ON
Dr Michael E Cox	University of British Columbia and The Vancouver Prostate Centre Vancouver, BC
Dr James R Davie	CancerCare Manitoba, Manitoba Institute of Cell Biology and University of Manitoba Winnipeg, MB
Dr Yves Fradet	Laval University and DiagnoCure Inc. Quebec, QC
Dr John Lewis	University of Alberta, National Institute of Nanotechnology and Translational Prostate Cancer Research Group Edmonton, AB
Dr Robyn Macfarlane	Dalhousie University Halifax, NS
Janet E A McDougall	McDougall Scientific Toronto, ON
Dr Arun Seth	Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto Toronto, ON
Dr Theodorus H Van Der Kwast	Mount Sinai Hospital and University Health Network Toronto, ON
Dr Vasundara Venkateswaran	University of Toronto and Sunnybrook Health Sciences Centre Toronto, ON
Dr Danny Vesprini, Science Officer	Sunnybrook Health Sciences Centre Toronto, ON
Aaron Bacher, Lay Member	Toronto, ON